Relative Strength Chart BerGenBio ASA

Equities

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-16 am EDT			5-day change	1st Jan Change
0.1306 ^NOK	+4.48%		-4.67%	-53.02%

Mar. 20	Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation	CI
Feb. 14	BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BERGENBIO ASA	Bio Therapeutic Drugs	+4.48%	-4.67%	-53.02%	-93.13%	-99.43%	47.7M